Karnataka
News Category

1win Charity Invests Over $170,000 in India, Targeting Elderly Care, Sports, Disaster Relief, and Environment
1win Charity's $170,000 commitment to India addresses critical needs in elderly care, sports infrastructure, flood recovery, and reforestation, signal...

Lantern Pharma Advances AI-Driven Oncology Pipeline and Establishes Open Medicine AI
Lantern Pharma's Q2 2026 results highlight significant pipeline progress and the spin-off of its AI platform, underscoring its strategic shift towards...

Lantern Pharma to Report Q2 2026 Results, Highlight AI Platform Advancements
Lantern Pharma's upcoming Q2 2026 webcast will detail financial results and progress on its AI-driven oncology platforms, underscoring the company's s...

Lantern Pharma Receives U.S. Patent Allowance for LP-184 Biomarker-Based Cancer Treatment Methods
Lantern Pharma announced a U.S. patent allowance for methods selecting patients for LP-184 using a three-gene biomarker signature, advancing precision...

Formycon and OneSource Specialty Pharma Forge Strategic Biosimilar Manufacturing Partnership
Formycon AG partners with OneSource Specialty Pharma to leverage India-based manufacturing for cost-efficient, high-quality biosimilar production, aim...

Lantern Pharma Launches AI-Powered ZetaOmics Computational Biology Platform
Lantern Pharma launched ZetaOmics, an AI-driven platform that automates bioinformatics and multi-omic analysis, expanding its commercial reach beyond ...

Academy Hunt Expands AI Course Comparison Database to Over 1,000 Listings, Aiding Student Decision-Making
Academy Hunt has expanded its database to include over 1,000 AI, machine learning, and data science course comparisons, providing a structured way for...

Quantum Genesis AI Clarifies Research Affiliation and Intellectual Property Rights
Quantum Genesis AI Corp. issues a statement to distinguish its research activities from those of Quantumzyme LLP, clarifying the transfer of intellect...

Lantern Pharma Raises $4.4 Million in Registered Direct Offering to Advance AI-Driven Precision Oncology
Lantern Pharma closed a $4.4 million registered direct offering, with potential for an additional $4.85 million from warrants, to fund its AI-powered ...


